Skip to main content
. 2016 Jan 19;10(2):262–274. doi: 10.5009/gnl15042

Fig. 7.

Fig. 7

Short-term results for clinical remission in the (A) steroids and (B) no steroids subgroups exposed to adalimumab versus placebo.

CI, confidence interval.